Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China flag China · Delayed Price · Currency is CNY
35.25
-0.05 (-0.14%)
Apr 29, 2026, 3:04 PM CST

SHE:300683 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
262.38648.33419.15510.22748.48184.05
Short-Term Investments
--4.560.3142.75491.39
Trading Asset Securities
161.14170.63449.69578.71144.04514.4
Cash & Short-Term Investments
423.52818.96873.41,0891,0351,190
Cash Growth
-43.85%-6.23%-19.81%5.21%-12.99%18.99%
Accounts Receivable
339.92298.58300.78254.58233.21264.48
Other Receivables
3.824.0600-3.18
Receivables
343.74302.64300.78254.58233.21270.15
Inventory
79.1682.94108.98117.41120.1871.65
Other Current Assets
391.6825.3323.1826.9855.4750.88
Total Current Assets
1,2381,2301,3061,4881,4441,583
Property, Plant & Equipment
648.35658.14729.69734.56654.23519.63
Long-Term Investments
42.0442.8516.5827.0888.8965.29
Goodwill
178.59178.59263.59263.59302.15316.17
Other Intangible Assets
223.18229.09253.44276.8890.3790
Long-Term Deferred Tax Assets
123.53120.52119.94109.4780.5971.64
Long-Term Deferred Charges
32.0734.5134.4931.962.622.39
Other Long-Term Assets
58.8682.97212.5739.5143.8749.87
Total Assets
2,5452,5772,9372,9712,7072,698
Accounts Payable
57.5533.1364.3552.0858.0551.72
Accrued Expenses
12.7518.7679.1159.8646.5146.42
Short-Term Debt
7.067.067.227.3230.0333.04
Current Portion of Long-Term Debt
44.9760.0114.8314.667.313.21
Current Portion of Leases
--5.124.80.71.87
Current Income Taxes Payable
6.324.573.872.842.464.52
Current Unearned Revenue
47.3253.7777.5411697.9966.38
Other Current Liabilities
121.3131.54111.2188.5841.6842.09
Total Current Liabilities
297.26308.85363.26346.15284.73249.25
Long-Term Debt
--11.5226.3240.9248.17
Long-Term Leases
3.653.95.3610.42.593.64
Long-Term Unearned Revenue
87.1683.0484.2530.4727.922.59
Long-Term Deferred Tax Liabilities
10.911.3514.7416.4813.117.25
Other Long-Term Liabilities
--45.9245.922.4523.56
Total Liabilities
398.96407.14525.05475.73371.7354.46
Common Stock
130.89130.89130.89130.89122.1122.1
Additional Paid-In Capital
1,8371,8371,8371,8371,5571,557
Retained Earnings
169.66192.71423.98510.34631.16645.19
Total Common Equity
2,1382,1612,3922,4782,3102,324
Minority Interest
7.998.8719.817.3724.7918.65
Shareholders' Equity
2,1462,1692,4122,4962,3352,343
Total Liabilities & Equity
2,5452,5772,9372,9712,7072,698
Total Debt
55.6770.9744.0563.581.5589.92
Net Cash (Debt)
367.85747.99829.351,026953.731,100
Net Cash Growth
-48.30%-9.81%-19.14%7.55%-13.29%10.72%
Net Cash Per Share
2.815.726.347.907.4810.34
Filing Date Shares Outstanding
128.03130.67130.89130.89122.1122.1
Total Common Shares Outstanding
128.03130.67130.89130.89122.1122.1
Working Capital
940.84921.02943.071,1421,1591,333
Book Value Per Share
16.7016.5318.2718.9318.9219.04
Tangible Book Value
1,7361,7531,8751,9381,9181,918
Tangible Book Value Per Share
13.5613.4114.3214.8015.7115.71
Buildings
--500.14500.38398.72350.14
Machinery
--528.75480.61339.05291.83
Construction In Progress
--11.022.99120.9934.27
Source: S&P Global Market Intelligence. Standard template. Financial Sources.